Home > Insider Trading > Filing (0000899243-21-048862)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1596946	Quotient Ltd	QTNT	In Vitro & In Vivo Diagnostic Substances (2835)	264719797

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1886129	Mohammad Khoury El	C/O Quotient Limited, B1, Business Park Terre Bonne, Route De Crassier 13 Eysins V8 1262	Chief Commercial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Ordinary Shares, Nil Par Value	Acquisiton	2021-12-16	50,000	$2.05	50,000	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Ordinary Shares	Restricted Stock Units	$0.00			300,148	300,148	Direct
Ordinary Shares	Ordinary Share Option (Right to Buy)	$2.91		2031-10-05	235,477	235,477	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
	300,148	300,148	Direct
2031-10-05	235,477	235,477	Direct

Footnotes

Restricted Stock Units convert into ordinary shares on a one-for-one basis.
On October 5, 2021, the Reporting Person was granted 300,148 Restricted Stock Units. The Restricted Stock Units will vest in three years, with 50% vesting on the first anniversary of the date of grant, and 25% vesting on each of the second and third anniversaries of the date of grant. The Restricted Stock Units were granted as an inducement grant pursuant to Nasdaq listing rule 5635(c)(4).
The option vests and becomes exercisable in three equal installments beginning October 5, 2022. The option was granted as an inducement grant pursuant to Nasdaq listing rule 5635(c)(4).